NewsRx

Search our medical news database

Finance

Depomed announces equity financing commitment of up to $30 million

Published in Obesity and Diabetes Week, January 8th, 2007

Depomed, Inc. (DEPO) announced that it has received a commitment of up to $30 million in common stock equity financing from Azimuth Opportunity Ltd.

These funds are available and may be drawn upon from time to time at Depomed's sole discretion over the next 24 months from the sales of registered common stock at a discount to the then prevailing market price. Acqua Capital Management is an advisor to Azimuth Opportunity Ltd.

"The equity line provides us financial flexibility to raise capital if needed in order to maintain a strong balance sheet," said John W. Fara, PhD, chairman, president and chief executive officer of Depomed. "This financial...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook